← Insider Monitor
Tarsus Pharmaceuticals, Inc. logo
TARS

Tarsus Pharmaceuticals, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Tarsus Pharmaceuticals is a biopharmaceutical company that develops treatments for eye and skin conditions, including its lotilaner-based product for Demodex blepharitis, a common eyelid condition caused by mite infestation.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Irvine, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Azamian Bobak R.President/CEO and Board ChairSell$803KNov 13, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for TARS.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable TARS activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.